News

About us

About us
We are a company dedicated to health, with national origin and global vocation.
Faes Farma Websites
All the websites that make up our business lines.
Whistle-blower channel
Internal information System (“Ethics Channel”).

Our purpose

Our mission, vision and values.

Our international presence

National pharmaceutical company with a global vocation.

Our history

We have been taking care of today and tomorrow for more than 90 years.

Our code of ethics

Our ethical principles are an integral part of our corporate culture.

Business

Business
We are engaged in the research, development, manufacture and marketing of prescription medicines, healthcare and animal nutrition products.
Products
A portfolio of premium Active Pharmaceutical Ingredients.

Direct commercialization

We market our own and third-party products.

Out-licensing

We license our own products.

CDMO

We help to develop successful projects.

In-licensing

Launching products from other laboratories.

R&D+i

R&D+i Strategy
Our strategic focus on research for the development and innovation of new medicines.
Therapeutic areas
We generate value for each of our therapeutic areas.

R&D+i News

Our progress in research, development and innovation.

Our clinical trials

We answer all frequently asked questions about clinical trials.

Business

Innovative and quality solutions with an integrated approach to health.

Sustainability

We guarantee integrity, transparency and commitment.

Sustainability

Commitment and SDGs
Our commitment to sustainability and meeting the SDGs.
Sustainability Strategy
Our strategy and sustainable performance in the past, present and future.
Environment
Our measures to reduce the environmental impact of our activity.
Social
Our commitment to society and to our employees.
Governance
Our commitment to integrate best practices in good governance.

Sustainability Policy

We manage responsibly, taking into account the concerns of our different stakeholders.

Integrated Report 2024

Sustainability Strategy

Find out more about our sustainability roadmap.

Whistle-blower channel

Internal information System (“Ethics Channel”).

Investors Ir a Inversores

Go to Investors
Corporate Governance
Get to know the main governing bodies, the General Shareholders’ Meetings or the internal regulations.
Investor’s corner
Space to consult the agenda, upcoming events and contact with the investor area of the company.

Capital Markets Day 2025 video

SIFI Acquisition Webcast

Q1 2026 Results

Annual Report

Talent

Working at Faes Farma
Behind every breakthrough, there are people who are passionate about what they do. At Faes Farma, we support them along their journey so they can give their very best.
Our values
Our values are the compass that guides every decision and every action we take.

Work with us

News

Resources
Access to the media library.
Press Contacts
Contact our Communications Department.

The latest from Faes Farma

Economic and Financial News

April 30th, 2026

Faes Farma exceeds €200 million in revenue (+31%) and increases its net profit by +9% in the first quarter

Revenue grew by +31%, exceeding guidance, driven by the strength of international markets, both in direct sales and licensing, alongside acquisitions. The Pharma business reached €175 million (+31%), with ophthalmology establishing itself […]

More info

Economic and Financial News

February 26th, 2026

Faes Farma increases its revenue by 23% to €627 million

Strong performance across all business areas enabled the company to close the 2025 financial year with organic revenue above guidance and adjusted EBITDA in line with expectations. The Pharma division achieved double-digit […]

More info

Economic and Financial News

November 4th, 2025

Faes Farma increases its revenue by more than 15% to €454 million

The company exceeds its revenue forecasts for the year as a whole thanks to the strong performance across all business areas The Pharma division posts double-digit growth (+13%) driven by strong performance […]

More info